🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Joel Pearson, PhD from CancerCare Manitoba Research & University of Manitoba presents Mechanisms Underlying YAP/TAZ-TEAD Function in #SCLC.   #MedTwitter

#CCTG CLC3 - A unique, patient focused trial explores if people with chronic lymphocytic #leukemia or small lymphocytic #lymphoma live longer with a better quality of life if they start treatment earlier: bit.ly/3YoxpYc #PatientsasPartners Annette Hay Dr. Versha Banerji

The INDIGO trial (nejm.org/doi/full/10.10…) shows that vorasidenib treatment delays tumor progression for patients with IDH-mutant glioma. Low Grade Glioma Registry and I summarized the science leading up to this groundbreaking outcome nejm.org/doi/full/10.10….

We Ask the Canadian Government to Increase CIHR’s Budget - Sign the Petition! chng.it/GCStH7qd via Change.org

Physician of the Week, Dr. Joel Nkosi follows Maya Angelou's advice in his work as an internal medicine physician. "People will forget what you said, people will forget what you did, but people will never forget how you made them feel." Read more at DRMB.ca/mdweek

Paul Wawryko was a pathologist specializing in pulmonary pathology. He worked at both HSC and St Boniface hospitals and had recently finished a fellowship at the Mayo Clinic - he even completed both the Boston and Chicago marathons #RIP Winnipeg Free Press passages.winnipegfreepress.com/passage-detail…

Well… this feels special 💜 Thank you Mayor Scott Gillingham City of Winnipeg. We’re honoured and privileged to promote inclusion in Nathan’s memory. Made possible by everyone who has supported, donated, and participated in #NathansMinions #cruisintochangelives @childrensrehab 🙏

Thanks Research at Canadian Cancer Society and all the donors for supporting our work on small cell lung cancer and the role of epigenetic plasticity in lung cancer evolution and drug resistance.

Fiddling while physicians burn(out)

Well deserved Joel. Long forward to working with this fabulous team of partners in research.

#SPAGN is a global network of sarcoma patient advocacy groups working to unite the global sarcoma community, share knowledge, strengthen our support systems for patients, and improve outcomes for sarcoma patients everywhere. Visit bit.ly/SPAGNmembers to learn more & join us!

Join us @ West Coast Sarcoma Conference for a comprehensive overview of the latest insights into #sarcoma diagnosis and management, strategies to enhance multidisciplinary treatment and more. ow.ly/C7z750QItXV Christine Simmons Shantanu Banerji 🇨🇦🇿🇲🇮🇳 #DrLeeCranmer #DrCarolineHolloway

The Ignite Lectures are an engaging event showcasing the five winners of the Ignite competition who will describe their projects. Takes place March 19. Details: eventscalendar.umanitoba.ca/site/research/…

🚨Early bird rates end soon - register today! Join chairs Christine Simmons, Dr. Lee Cranmer, Dr. Caroline Holloway Shantanu Banerji 🇨🇦🇿🇲🇮🇳 @ Canada’s premier event designed to address knowledge gaps in the multidisciplinary treatment & management of #sarcoma. 👉 ow.ly/j2j450QQoCA #WCS2024

Learnings from building an AYA program in Manitoba. Still a long road to travel. Grateful to ⁦CancerCare Manitoba⁩ and ⁦CancerCare Manitoba Foundation⁩ for supporting this program! ⁦AYACan.cancer⁩ ⁦University of Manitoba⁩ ⁦CancerCare Manitoba Research⁩ ⁦ mdpi.com/1718-7729/31/5…

Looking forward to participating in the CCRAN Biomarkers Conference session: Feasible opportunities to adopt CGP in Canada: an international perspective, with Shantanu Banerji 🇨🇦🇿🇲🇮🇳 Dr. Cathy Eng and Don Husereau Join us if you can! bit.ly/BiomarkersConf…

July is #SarcomaAwarenessMonth. Join us in raising awareness and supporting those affected by the battle against Sarcoma. #CCTG is inspired by the strength and resilience of all patients and families. We are committed to advancing research and helping improve lives.

Soft-tissue sarcomas are very aggressive cancers of the muscles, fat, and connective tissues. With little progress for decades, a breakthrough is game-changing. This #SarcomaAwarenessMonth, we are highlighting a clinical trial funded by #StandUpToCancer, which showed very

Dr. Sapna Oberoi Sapna Oberoi (She/her) presenting outcomes of ARST0332 at the CTOS 2024 annual meeting. And she co-chaired the session too! CancerCare Manitoba Foundation CancerCare Manitoba Research University of Manitoba

Exploring the rapidly evolving therapies in oncogene-driven advanced NSCLC! This new review dives into targeted agents for alterations in MET, HER2, KRAS, and emerging targets like NRG1 & PI3K. Read about the clinical advancements and future directions: journals.sagepub.com/doi/epdf/10.11…